1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs.

MONALEESA-7: doi.org/10.1056/NEJMoa1903765
Free drug samples are a marketing tool: doi.org/10.2105/AJPH.2007.114249

Back us on Patreon! www.patreon.com/plenarysession